Patent Assignment
Reel/Frame 035571/0926
Change of Name
Recorded: 2015-05-04
Pages: 20
Assignor
BIOGEN IDEC MA INC.
Executed: 2015-03-23
Assignee
BIOGEN MA INC.
250 BINNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(420)
Anti-CD4 Antibody Homologs Useful in Prophylaxis and Treatment of Aids, Arc and Hiv Infection
Patent:
5,871,732 →
Application:
07/916,098 →
Tat-Derived Transport Polypeptides
Patent:
6,316,003 →
Application:
08/235,403 →
Vascular Cell Adhesion Molecule (Vcam) Polypeptides
Patent:
6,252,043 →
Application:
08/310,890 →
Dna Sequences, Recombinant Dna Molecules and Processes for Producing Human Fibroblast Interferon-Like Polypeptides
Patent:
7,588,755 →
Application:
08/449,930 →
Tat-Derived Transport Polypeptide Conjugates
Patent:
5,747,641 →
Application:
08/451,233 →
Dna Sequences, Recombinant Dna Molecules and Processes for Producing Human Fibroblast Interferon-Like Polypeptides
Patent:
7,635,466 →
Application:
08/452,658 →
Recombinant Anti-Vla-4 Antibody Molecules
Patent:
6,602,503 →
Application:
08/454,899 →
Compositions and Methods for Modulating Leukocyte Adhesion to Brain Endothelial Cells
Patent:
6,033,665 →
Application:
08/457,847 →
Polypeptides Displaying Hbv Antigenicity or Hbv Antigen Specificity
Patent:
6,297,355 →
Application:
08/472,301 →
Method of Making and Binding Caip Polypeptides
Patent:
6,171,800 →
Application:
08/474,697 →
Caip-Like Gene Family
Patent:
5,641,748 →
Application:
08/475,894 →
Synthetically Prepared Polypeptides Displaying Hbv Antigenicity or Hbv Antigen Specificity and Compositions, Methods and Diagnostic Kits Using Them
Patent:
6,268,122 →
Application:
08/480,118 →
Vcam Fusion Proteins and Dna Coding Therefor
Patent:
6,307,025 →
Application:
08/482,073 →
The Caip-Like Gene Family
Patent:
5,837,844 →
Application:
08/484,709 →
Caip-Like Gene Family
Patent:
5,656,438 →
Application:
08/484,710 →
Recombinant Dna Molecules and Their Method of Produciton
Patent:
6,270,955 →
Application:
08/486,592 →
Dna Sequences, Recombinant Dna Molecules and Transformed Host Cells for Producing Human Interferon-Like Polypeptides
Patent:
6,835,557 →
Application:
08/487,280 →
Soluble Lymphotoxin-Beta Receptors and Anti-Lymphotoxin Receptor and Ligand Antibodies as Therapeutic Agents for the Treatment of Immunological Disease
Patent:
5,925,351 →
Application:
08/505,606 →
The Caip-Like Gene Family
Patent:
6,423,824 →
Application:
08/671,354 →
Treatment for Asthma with Vla-4 Blocking Agents
Patent:
5,871,734 →
Application:
08/822,830 →
Novel Muteins of Ifn-B
Patent:
6,127,332 →
Application:
08/912,768 →
Soluble Lymphotoxin-B Receptors as Therapeutic Agents for the Treatment of Immunological Disease
Patent:
6,403,087 →
Application:
09/000,166 →
Treatment for Inflammatory Bowel Disease with a Vcam-1/1GG Fusion Protein
Patent:
6,482,409 →
Application:
09/157,452 →
Ret Ligand (Retl) for Stimulating Neutral and Renal Growth
Patent:
6,677,135 →
Application:
09/187,906 →
Common Gamma Chain Monoclonal Antibody Blocking Agents
Patent:
6,323,027 →
Application:
09/189,129 →
Kidney Injury-Related Molecules
Patent:
6,664,385 →
Application:
09/197,970 →
Tumor Necrosis Factor Related Ligand
Patent:
7,129,061 →
Application:
09/245,198 →
Use of Lymphotoxin-Beta Receptor Blocking Agents for the Treatment of Antibody Mediated Immunological Diseases
Patent:
7,255,854 →
Application:
09/299,139 →
Novel Hepatitis B Virus Inhibitors
Patent:
6,544,520 →
Application:
09/302,087 →
Soluble Lymphoto in-Beta Receptors and Anti-Lymphotoxin Receptor and Ligand Antibodies as Therapeutic Agents for the Treatment of Immunological Disease
Patent:
6,669,941 →
Application:
09/303,262 →
Antibodies to Ret and RETL3
Patent:
6,861,509 →
Application:
09/489,407 →
Methods and Compositions for Therapies Using Genes Encoding Secreted Proteins Such as Interferon-Beta
Patent:
6,696,423 →
Application:
09/512,946 →
Hydrophobically-Modified Protein Compositions and Methods
Patent:
6,897,297 →
Application:
09/579,680 →
Treatment of Follicular Lymphomas Using Inhibitors of the Lt Pathway
Patent:
7,060,667 →
Application:
09/626,219 →
Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Protein Compositions
Common Gamma Chain Blocking Agents
Polymer Conjugates of Interferon Beta-1A and Uses
Hbv Core Antigen Particles with Multiple Immunogenic Components Attached via Peptide Ligands
Method for the Treatment of Inflammatory Disorders
Soluble Lymphotoxin-Beta Receptors as Therapeutic Agents for the Treatment of Systemic Lupus Erythematosus
Baff Receptor (Bcma), an Immunoregulatory Agent
Methods for Inhibiting Lymphotoxin Beta Receptor Signalling
Methods of Treatment by Administering an Anti-Bcma Antibody
Methods of Treating a Tumor That Expresses April by Administering Bcma
Caip-Like Gene Family
Heterologous Polypeptide of the Tnf Family
Treatment for Inflammatory Bowel Disease with a Fibronectin Polypeptide
Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Method for Promoting Neovascularization
Nucleic Acids Encoding Train-R: a Cysteine Rich Member of the Tnf-Receptor Family
Renal Regulatory Elements and Methods of Use Thereof
Polymer Conjugates of Mutated Neublastin
Nucleic Acids Encoding Baff Receptor, Chimeric Proteins and Methods and Compositions Related Thereto
Methods and Compositions for Therapies Using Genes Encoding Secreted Proteins Such as Interferon-Beta
Treatment for Inflammatory Bowel Disease
Hbv Capsid-Binding Peptide Immunogens
Antibodies to Vla-1
Anti-ALPHAVBETA6 Antibodies
Tri-Substituted Heteroaryls and Methods of Making and Using the Same
Humanized Antibodies Against Monocyte Chemotactric Proteins
Kim-1 Antagonists and Use to Modulate Immune System
Expression Cassette and Vector for Transient or Stable Expression of Exogenous Molecules
Truncated Baff Receptors
Nogo Receptor Binding Protein
Polymer-Conjugated Glycosylated Neublastin
A Method of Treating a Patient Having an Autoimmune Disorder by Administering an Antibody That Binds Human Baffr
Method of Enhancing Delivery of a Therapeutic Nucleic Acid
Novel Neurotrophic Factors
Cripto Blocking Antibodies and Uses Thereof
Molecules and Methods for Inhibiting Shedding of Kim-1
Composition for and Treatment of Demyelinating Diseases and Paralysis by Administration of Remyelinating Agents
Polymer Conjugates of Interferon Beta-1A and Uses
Reversal of Viral-Induced Systemic Shock and Respiratory Distress by Blockade of the Lymphotoxin Beta Pathway
Antibodies Against Monocyte Chemotactic Proteins
Hbv Core Antigen Particles with Multiple Immunogenic Components Attached via Peptide Ligands
Purification and Preferential Synthesis of Binding Molecules
Polyalkylene Polymer Compounds and Uses Thereof
Antagonists of Tweak and of Tweak Receptor and Their Use to Treat Immunological Disorders
Cripto-Specific Antibodies
Neublastin Expression Constructs
Antibodies Specifically Reactive with a Tumor Necrosis Factor Related Ligand
Tumor Necrosis Factor Related Ligand
Humanized Anti-VLA4 Immunoglobulins
Methods and Constructs for Expressing Polypeptide Multimers in Eukaryotic Cells Using Alternative Splicing
Method for the Treatment of Inflammatory Disorders
Treatment of Conditions Involving Demyelination
Methods of Promoting Neurite Outgrowth with Soluble Taj Polypeptides
Hbv Core Antigen Particles with Multiple Immunogenic Components Attached via Peptide Ligands
Molecules and Methods for Inhibiting Shedding of Kim-1
Antibodies Having Altered Effector Function and Methods for Making the Same
Methods of Humanizing Immunoglobulin Variable Regions Through Rational Modification of Complementarity Determining Residues
Train-R: a Cysteine-Rich Member of the Tnf-Receptor Family
Treatment of Follicular Lymphomas Using Inhibitors of the Lt Pathway
A Tumor Necrosis Factor Related Ligand
Tumor Necrosis Factor Related Ligand
Baff Receptor Antibodies and Methods
Baff Receptor Polypeptides
Methods of Monitoring Treatment of Baff-R Related Disease
Anti-Alpha(V)Beta(6) Antibodies and Uses Thereof
Receptor Coupling Agents and Compositions Thereof
Administration of Agents for the Treatment of Inflammation
Antagonists of Tweak and of Tweak Receptor and Their Use to Treat Immunological Disorders
Anti-CD154 Antibodies
Refolding Transforming Growth Factor Beta Family Proteins
Neublastin Variants
Treatment for Asthma with ALPHA4-Specific Antibodies
Methods of Treating Pain Using Neurotrophic Factors
Methods For Producing Mammalian Cells
Binding Molecules and Methods of Use Thereof
Methods of treating inflammatory and autoimmune diseases with natalizumab
Application:
11/711,628 →
Publication:
US 2007/0207141
Treatment of Multiple Sclerosis with Vla-4- Binding Antibody
Application:
11/719,660 →
Publication:
US 2009/0202527
Detection and Quantitation of Cyclodextrins
Stabilized Polypeptide Compositions
Anti-Igf-1R Antibodies and Uses Thereof
Method for Delivering Interferon-Beta
Cripto Blocking Antibodies and Uses Thereof
Kim-1 Antibodies for Treatment of TH2-Mediated Conditions
Compositions and Methods for Inhibiting Growth of SMAD4-Deficient Cancers
Multispecific Binding Molecules Comprising Connecting Peptides
Methods and Products for Evaluating an Immune Response to a Therapeutic Protein
Soluble Lymphotoxin-Beta Receptors and Anti-Lymphotoxin Receptor and Ligand Antibodies as Therapeutic Agents for the Treatment of Immunological Diseases
SP35 Antibodies and Uses Thereof
Stabilized Polypeptide Compositions
Stabilized polypeptide compositions
Molecules and Methods for Inhibiting Shedding of Kim-1
Tweak Binding Antibodies
Measurement of Soluble Tweak Levels for Evaluation of Lupus Patients
Stable liquid interferon-beta formulations
Stable liquid interferon formulations
Application:
11/975,380 →
Publication:
US 2008/0050339
Soluble Lymphotoxin-Beta Receptor Fusion Protein and Methods for Inhibiting Lymphotoxin Beta-Receptor Signaling
Antibodies to Vla-1
Methods of Activating Ret Receptor Tyrosine Kinase Using Neurotrophic Factors
BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders
Methods for Use with Baff Antagonists
Methods of Evaluating Baff
Platelet Aggregation Assays Using a CD40L-Binding Agent
Treatment of Conditions Involving Demyelination
Application:
12/095,857 →
Publication:
US 2009/0175872
Modified Binding Molecules Comprising Connecting Peptides
Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
Application:
12/152,622 →
Publication:
US 2009/0252729
Nogo Receptor Antagonists
Polymer Conjugates of Mutated Neublastin
Antibodies Against Monocyte Chemotactic Proteins
Methods of Inhibiting Alpha-4-Dependent Interactions with Vcam-1 with Anti-Vla-4 Antibodies
Anti-Alpha V Beta 6 Antibodies
Method for the Treatment of Inflammatory Disorders
Treatments for Neurological Disorders
Compositions and Methods for Administering Gdnf Ligand Family Proteins
Application:
12/281,077 →
Publication:
US 2010/0056440
Method of Treating Lung Fibrosis Using ST2 Polypeptide
Methods of Treating Stroke and Traumatic Brain Injury Using Humanized AQC2 Anti-Vla-1 Antibodies
Cripto Blocking Antibodies and Uses Thereof
Recombinant Anti-VLA4 Antibody Molecules
Methods for Promoting Myelination, Neuronal Survival and Oligodendrocyte Differentiation Via Administration of SP35 or TrkA Antagonists
Method for Distribution of a Drug
Application:
12/376,697 →
Publication:
US 2011/0184747
SP35 Antibodies and Uses Thereof
Cripto Blocking Antibodies and Uses Thereof
Methods for Treating Tweak-Related Conditions
Method of Isolating Biomacromolecules Using Polyalkylene Glycol and Transition Metals
Application:
12/425,328 →
Publication:
US 2009/0292109
Indazole Derivatives as Modulators of Interleukin-1 Receptor-Associated Kinase
Composition Comprising Antibodies to Lingo or Fragments Thereof
Method of Isolating Biomacromolecules Using Low pH and Divalent Cations
Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation
Neuroprotection in Demyelinating Diseases
Application:
12/525,805 →
Publication:
US 2010/0130607
Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof
Nutrient Monitoring and Feedback Control for Increased Bioproduct Production
Systems and Methods for Evaluating Chromatography Column Performance
Method for the High Level Expression of Active Tumor Necrosis Receptor Family Member Immunoglobulin Fusion Proteins
Kim-1 Antagonists and Use to Modulate Immune System
Application:
12/548,366 →
Publication:
US 2010/0080798
Anti-Igf-1R Antibodies and Uses Thereof
Compositions Comprising Variant Lt-B-R-Ig Fusion Proteins
Immunoglobulin Formulation and Method of Preparation Thereof
Treatment of Follicular Lymphoma Using Inhibitors of the Lt Pathway
Heterobicyclic Sphingosine 1-Phosphate Analogs
Bicyclic Aryl Sphingosine 1-Phosphate Analogs
Methods for Increasing Vascularization
Light Targeting Molecules and Uses Thereof
Methods of Reducing Chemotaxis Using Antibodies Against Monocyte Chemotactic Proteins
Methods of Humanizing Immunoglobulin Variable Regions Through Rational Modification of Complementarity Determining Residues
Neurotrophic Factors and Methods of Use Thereof
Biomarkers for Predicting Anti-Tnf Responsiveness or Non-Responsiveness
Application:
12/663,335 →
Publication:
US 2010/0303813
Compositions and Methods for the Treatment of Progressive Multifocal Leukoencephalopathy (Pml)
Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists
Application:
12/682,505 →
Publication:
US 2010/0297121
Methods of Decreasing Tumor Volume and Reducing Tumor Burden Using Tnf-Receptor-Coupling Agents
Nogo Receptor Binding Protein
Truncated Baff Receptors
Method of Identifying Compounds That Bind Baff-R
Antibodies to Vla-1
Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination
Application:
12/741,957 →
Publication:
US 2011/0123553
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Compositions and Methods to Treat Acute Myelogenous Leukemia
Application:
12/761,853 →
Publication:
US 2010/0266587
Methods of Treating Multiple Sclerosis with Stable Liquid Interferon-Beta Formulations
Soluble Lymphotoxin-Beta Receptors and Anti-Lymphotoxin Receptor and Ligand Antibodies as Therapeutic Agents for the Treatment of Immunological Diseases
Automated System And Method For Monitoring Chromatography Column Performance, And Applications Thereof
Recombinant Anti-VLA4 Antibody Molecules
A Method of Treating a Patient Having an Autoimmune Disorder by Administering an Antibody That Binds Human Bcma
Nucleic Acids Encoding Antibodies Having Altered Effector Function and Methods for Making the Same
Antibodies to Vla-1
Humanized Antibodies Against Monocyte Chemotactic Proteins
Methods for Inhibiting Lymphotoxin-Beta Receptor Signaling in TH1 Cell-Associated Disorders
Taci as an Anti-Tumor Agent
Application:
13/044,317 →
Publication:
US 2012/0189634
SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO
Application:
13/047,534 →
Publication:
US 2011/0243966
Therapies for Chronic Renal Failure Using One or More Integrin Antagonists
Application:
13/049,888 →
Publication:
US 2011/0305686
Anti-Alpha V Beta 6 Antibodies and Uses Thereof
Recombinant FcRn and Variants Thereof for Purification of Fc-Containing Fusion Proteins
Application:
13/125,795 →
Publication:
US 2012/0021484
Arginine Inactivation of Viruses
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
Anti-Lymphotoxin Antibodies
Application:
13/141,297 →
Publication:
US 2012/0003235
Methods of Treating Lupus Nephritis Using Antibodies Against Monocyte Chemotactic Proteins
Antagonists of Tweak and of Tweak Receptor and Their Use to Treat Immunological Disorders
Cripto Blocking Antibodies and Uses Thereof
Method for Inhibiting Baff-R Activity
Method of Treating Immunological Disorders by Administering Truncated Baff Receptors
Tweak Binding Antibodies
Application:
13/228,784 →
Publication:
US 2012/0009178
Polyalkylene Polymer Compounds and Uses Thereof
Method of Treating Lupus Nephritis
Methods and Products for Evaluating an Immune Response to a Therapeutic Protein
Composition Comprising Antibodies to Lingo or Fragments Thereof
Methods for Treating Inflammatory Bowel Disease
Treatment of Melanoma with Interferon-Beta and Ras-Raf-Mek-Erk Inhibitor Combination Therapy
Application:
13/247,556 →
Publication:
US 2012/0082647
Purification of Immunoglobulins
Anti-Bcma Antibodies
Method for the Treatment of Inflammatory Disorders
Stable Preserved Compositions of Interferon-Beta
Application:
13/301,354 →
Publication:
US 2012/0269770
Method of Treating a Patient Having an Autoimmune Disorder by Administering Baffr Polypeptide
Sp35 Antibodies and Uses Thereof
Methods of Targeting Baff
Application:
13/365,083 →
Publication:
US 2012/0214683
Treatment for Multiple Sclerosis
Methods for Inhibiting Yellow Color Formation in a Composition
Application:
13/384,178 →
Publication:
US 2012/0183531
Bicyclic Aryl Sphingosine 1-Phosphate Analogs
Heteroaryl Btk Inhibitors
Bruton's Tyrosine Kinase Inhibitors
Methods of Screening for a Compound That Inhibits the Interaction Between Baff and Bcma
Nogo Receptor Binding Protein
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Polymer-Conjugated Glycosylated Neublastin
Biomarkers Predictive of Therapeutic Responsiveness to Ifnb and Uses Thereof
Application:
13/441,745 →
Publication:
US 2012/0328567
Methods of Evaluating Baff
Methods of Preventing and Removing Trisulfide Bonds
Anti-Vla-4 Related Assays
Method of Supplementing Culture Media to Prevent Undesirable Amino Acid Substitutions
Assay for Jc Virus Antibodies
Methods of Treating Inflammatory Disorders Using High Concentration Natalizumab Compositions
Detection and Quantitation of Cyclodextrins
Regeneration of Chromatography Material
Patent:
9,102,709 →
Application:
13/543,650 →
Method for Increasing Expression of Active Tumor Necrosis Factor Receptor Family Member-Ig Fusion Proteins
Polymer Conjugates of Interferon Beta-1A and Uses
Treatment Using Neublastin Polypeptides
Application:
13/603,202 →
Publication:
US 2013/0130981
Immunoglobulin Formulation and Method of Preparation Thereof
Bicyclic Aryl Sphingosine 1-Phosphate Analogs
Anti-Vla-4 Antibodies
Application:
13/641,199 →
Publication:
US 2014/0161794
Method of Treating B Cell Cancers by Administering Truncated Baff Receptors
Heterobicyclic sphingosine 1-phosphate analogs
Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof
Nutrient Monitoring and Feedback Control for Increased Bioproduct Production
Method for Treating Multiple Sclerosis and Crohn's Disease
Compositions and Methods for Increasing Vascularization
Treatment of Autoimmune Disorders
Application:
13/682,221 →
Publication:
US 2013/0259861
Treating Neurological Disorders
NRF2 Screening Assays and Related Methods and Compositions
Application:
13/767,014 →
Publication:
US 2013/0317103
CD40L-Binding Agent Based Platelet Aggregation Assays
Methods of Evaluating Baff
Screening Methods for Identifying SP35 Antagonists
Composition Comprising Antibodies to LINGO or Fragments Thereof
Application:
13/802,503 →
Publication:
US 2013/0323786
NRF2 Screening Assays and Related Methods and Compositions
Application:
13/804,283 →
Publication:
US 2013/0303613
Ltbr Blockade: Methods for Optimizing Therapeutic Responsiveness of Patients
Application:
13/816,691 →
Publication:
US 2013/0216557
Rapid Generation of Anti-Idiotypic Antibodies
Pharmaceutical Compositions Containing Dimethyl Fumarate
Application:
13/827,228 →
Publication:
US 2013/0295169
Nogo Receptor Binding Protein
Anti-Lymphotoxin Antibodies
Application:
13/830,500 →
Publication:
US 2014/0079716
Sp35 Antibodies and Uses Thereof
Neuroprotection in Demyelinating Diseases
Application:
13/850,240 →
Publication:
US 2013/0287732
Methods for Treating Tweak-Related Conditions
Antibodies Against Monocyte Chemotactic Proteins
Compositions and Methods for Inhibiting Growth of SMAD4-Deficient Cancers
Patent:
44,681 →
Application:
13/863,646 →
METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMadCAM LEVELS
Application:
13/881,520 →
Publication:
US 2013/0337470
Heterocyclic Tyrosine Kinase Inhibitors
Humanized Antibodies Against Monocyte Chemotactic Proteins
Application:
13/933,453 →
Publication:
US 2014/0079697
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
Stable Liquid Interferon Beta Formulations
Novel Receptor Nucleic Acids and Polypeptides
Application:
13/958,123 →
Publication:
US 2014/0187485
Selection and Treatment of Subjects
Application:
13/981,699 →
Publication:
US 2014/0017261
S1P Modulating Agents
Linker Peptides and Polypeptides Comprising Same
Polyalkylene Polymer Compounds and Uses Thereof
Application:
14/015,711 →
Publication:
US 2015/0132259
Method for the Treatment of Inflammatory Disorders
Automated System and Method for Monitoring Chromatography Column Performance, and Applications Thereof
Application:
14/041,318 →
Publication:
US 2014/0067308
Treatment Using Neublastin Polypeptides
Application:
14/077,700 →
Publication:
US 2014/0349930
Methods for Use with Baff Antagonists
Application:
14/086,352 →
Publication:
US 2014/0213470
Spectroscopic Analysis of Nutrient Materials for Use in a Cell Culture Process
Limiter for a Dispensing Device
Methods of Preventing and Removing Trisulfide Bonds
Methods of Treating Multiple Sclerosis and Preserving and/or Increasing Myelin Content
Application:
14/119,373 →
Publication:
US 2014/0163100
Method of Assessing Risk of Pml
Application:
14/122,754 →
Publication:
US 2014/0322164
Process for Preparing High Purity and Crystalline Dimethyl Fumarate
Pro-Coagulant Compounds and Methods of Use Thereof
Drug Labeling Tool
Application:
14/128,790 →
Publication:
US 2014/0222448
Arginine-Free Tnfr:Fc-Fusion Polypeptide Compositions and Methods of Use
Anti-CD154 Antibodies
Nogo Receptor Antagonists and Methods of Increasing Neurite Outgrowth
Methods of Treating Central Nervous System Ischemic or Hemorrhagic Injury Using Anti ALPHA4 Integrin Antagonists
Application:
14/152,205 →
Publication:
US 2014/0127195
Therapies for Chronic Renal Failure Using One or More Integrin Antagonists
Application:
14/158,764 →
Publication:
US 2014/0234299
Anti-Alpha(v)Beta(6) Antibodies and Uses Thereof
Application:
14/161,207 →
Publication:
US 2014/0294809
Methods of Evaluating Baff
Biomarkers for Multiple Sclerosis and Methods of Use Thereof
Application:
14/192,356 →
Publication:
US 2015/0031562
Deuterium Substituted Fumarate Derivatives
Factor VIII Polypeptide Formulations
Refolding Transforming Growth Factor Beta Family Proteins
Heterodimeric Fc Regions, Binding Molecules Comprising Same, and Methods Relating Thereto
Assay for Detection of Jc Virus Dna
Application:
14/235,856 →
Publication:
US 2014/0255915
Methods of Treating Progressive Forms of Multiple Sclerosis Comprising Subcutaneously Administering Daclizumab
Use of Nuclear Magnetic Resonance and Near Infrared to Analyze Biological Samples
Neuroprotection in Demyelinating Diseases
Application:
14/264,653 →
Publication:
US 2014/0323570
Cholesterol-Based Media Supplements for Cell Culture
Application:
14/278,046 →
Publication:
US 2014/0363845
Aglycosyl Anti-CD154 (CD40 Ligand) Antibodies and Uses Thereof
Application:
14/280,215 →
Publication:
US 2015/0017155
Bicyclic Aryl Sphingosine 1-Phosphate Analogs
Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof
Bruton's Tyrosine Kinase Inhibitors
Methods and Products for Evaluating an Immune Response to a Therapeutic Protein
Method for Delivering Interferon-Beta
ANTI-TIM-1 Antibodies And Uses Thereof
Application:
14/359,784 →
Publication:
US 2015/0110792
Silicon-Containing Fumaric Acid Esters
Enhancement of Transport of Therapeutic Molecules Across the Blood Brain Barrier
Methods of Reducing Immunogenicity Against Factor Viii in Individuals Undergoing Factor Viii Therapy
Chimeric Factor Viii Polypeptides and Uses Thereof
Factor Viii Compositions and Methods of Making and Using Same
Recombinant Factor Viii Proteins
High-Throughput Method For Sialic Acid Quantitation
Application:
14/380,983 →
Publication:
US 2015/0038362
Jcv Neutralizing Antibodies
Jcv Neutralizing Antibodies
Biomarkers for Use in Integrin Therapy Applications
Application:
14/387,762 →
Publication:
US 2015/0086570
Delivery Device and Components Thereof
Application:
14/387,939 →
Publication:
US 2015/0057608
Methods of Detecting Glycosaminoglycans
Cognitive Composite Parameters and Uses Thereof for Evaluating Multiple Sclerosis
Lingo-2 Antagonists for Treatment of Conditions Involving Motor Neurons
Trapping Reagents for Reactive Metabolites Screening
Inhibitors of Bruton's Tyrosine Kinase
Chimeric Clotting Factors
Procoagulant Compounds
Pyrimidinyl Tyrosine Kinase Inhibitors
Device Container
Cell Line Expressing Single Chain Factor Viii Polypeptides and Uses Thereof
Factor Viii Complex with Xten and Von Willebrand Factor Protein, and Uses Thereof
Blood Factor Monitoring Assay and Uses Thereof
Compounds That Are S1P Modulating Agents and/or Atx Modulating Agents
Atx Modulating Agents
Atx Modulating Agents
Methods and Compositions for Inactivating Enveloped Viruses
Compounds That Are S1P Modulating Agents and/or Atx Modulating Agents
Compounds That Are S1P Modulating Agents and/or Atx Modulating Agents
Disease Progression Parameters and Uses Thereof for Evaluating Multiple Sclerosis
Application:
14/421,561 →
Publication:
US 2015/0220693
Methods of Using Fix Polypeptides
Application:
14/430,848 →
Publication:
US 2015/0252345
Methods of Using a Fixed Dose of a Clotting Factor
Methods of Modulating Immunological Responses by Administering Truncated Baff Receptors
Application:
14/444,139 →
Publication:
US 2015/0023961
Anti-alpha(v)beta(6) Antibodies
Steroid Sparing Agents and Methods of Using Same
Application:
14/444,862 →
Publication:
US 2015/0056205
Methods of Treating a Patient Having an Autoimmune Disorder by Administering a Soluble Bcma
Methods of Treating Autoimmune Diseases Using a B-Cell Maturation Antigen (Bcma)
Treatment of Severe Multiple Sclerosis
Application:
14/455,301 →
Publication:
US 2015/0030590
Therapeutic Uses of Humanized Antibodies Against Alpha-4 Integrin
Application:
14/469,863 →
Publication:
US 2015/0064177
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
Application:
14/523,451 →
Publication:
US 2015/0203585
Immunoglobulin Formulation and Method of Preparation Thereof
Application:
14/524,687 →
Publication:
US 2015/0044206
Treatment of Neurodegeneration and Neuroinflammation
Application:
14/540,136 →
Publication:
US 2015/0132747
Nogo Receptor Binding Protein
Application:
14/557,653 →
Publication:
US 2015/0177240
Extended Treatment of Multiple Sclerosis
Application:
14/561,503 →
Publication:
US 2015/0175703
Isolation and Use of Human Regulatory T Cells
Application:
14/563,219 →
Publication:
US 2015/0210982
Stable Liquid Interferon Beta Formulations
Anti-Neublastin Antibodies and Uses Thereof
Anti-Bcma Antibodies
Application:
14/596,769 →
Publication:
US 2015/0125460
Antibodies to Vla-1
Methods for the Detection of Jc Polyoma Virus
Administration of Agents for the Treatment of Inflammation
Application:
14/613,821 →
Publication:
US 2015/0152182
Heterobicyclic Sphingosine 1-Phosphate Analogs
Control of Protein Glycosylation by Culture Medium Supplementation and Cell Culture Process Parameters
Application:
14/625,559 →
Publication:
US 2016/0237399
Taci as an Anti-Tumor Agent
Application:
14/631,217 →
Publication:
US 2015/0218247
Methods of Preventing and Removing Trisulfide Bonds
Arginine Inactivation of Viruses
Application:
14/659,409 →
Publication:
US 2016/0010063
Methods For Treating Tweak-Related Conditions
Application:
14/661,391 →
Publication:
US 2015/0291688
Pharmaceutical Compositions Containing Dimethyl Fumarate
Application:
14/679,716 →
Publication:
US 2015/0209318
Limiter for Dispensing Device
Patent:
660,418 →
Application:
29/390,681 →
Medicament Delivery Device
Patent:
707,352 →
Application:
29/393,456 →
Syringe
Patent:
751,705 →
Application:
29/468,730 →
Package
Patent:
741,703 →
Application:
29/478,806 →
Prodrugs and Drugs
Application:
61/990,518 →
Biomarkers Predictive of Lupus Progression and Uses Thereof
Application:
61/991,939 →
Methods for the Detection of Amyloid Beta Oligomers in Biological Samples
Application:
61/993,853 →
Atx Modulating Agents
Application:
62/008,951 →
Methods for the Detection and Measurement of Amyloid Beta in Biological Samples
Application:
62/011,960 →
Optimized Factor Ix Gene
Application:
62/019,069 →
Cross-Scale Modeling of Bioreactor Cultures Using Raman Spectroscopy
Application:
62/020,371 →
IRAK4 Inhibiting Agents
Application:
62/026,214 →
Prodrugs and Drugs
Application:
62/031,530 →
Compositions and Methods for Treatment of Sickle Cell Disease
Application:
62/033,436 →
Characterization of Cystine Knot Superfamily Proteins
Application:
62/034,523 →
Anti-CD40 Antibodies and Uses Thereof
Application:
62/038,773 →
Compositions and Methods for Treatment of Sickle Cell Disease
Application:
62/043,629 →
Systems and Methods for Assessing Therapeutic Proteins
Application:
62/046,446 →
Humanized Anti-Alpha V Beta 5 Antibodies and Uses Thereof
Application:
62/049,987 →
Systems and Methods for Characterization of Multiple Sclerosis
Application:
62/050,069 →
Copper Supplementation for Control of Glycosylation in Mammalian Cell Culture Process
Application:
62/065,454 →
Anti-Gpiib/Iiia Antibodies and Uses Thereof
Application:
62/067,783 →
Diterpenoid Derivatives and Methods of Use Thereof
Application:
62/068,447 →
Hypotaurine and Choline for Control of Waste Byproduct Accumulation in Mammalian Cell Culture Process
Application:
62/073,300 →
ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES
Application:
62/073,348 →
Biomarkers Predictive of Lupus Progression and Uses Thereof
Application:
62/079,813 →
Methods of Treating Multiple Sclerosis
Application:
62/080,783 →
Pharmaceutical Bead Formulations Comprising Dimethyl Fumarate
Application:
62/081,889 →
Pharmaceutical Matrix Formulations Comprising Dimethyl Fumarate
Application:
62/081,907 →
Methods and Compositions for Controlling Antibody Aggregation
Application:
62/086,629 →
Methods of Treating Multiple Sclerosis
Application:
62/087,675 →
Methods and Apparatuses for Compound Dispersion
Application:
62/094,265 →
Combination Therapies and Uses for Treatment of Demyelinating Disorders
Application:
62/101,336 →
Formulations and Screening of Biological Therapeutic Agents
Application:
62/104,798 →
Anti-CD40 Antibody Formulations
Application:
62/104,801 →
Therapeutic Protein Formulations
Application:
62/104,804 →
Anti-Gpiib/Iiia Antibodies and Uses Thereof
Application:
62/110,883 →
Methods and Compositions for Detecting Therapeutic Nucleic Acids
Application:
62/115,102 →
Drug Delivery Dose Indicator
Application:
62/127,005 →
Anti-Tnf-Alpha Polypeptide Composition and Use Thereof
Application:
62/132,839 →
Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases
Application:
62/136,431 →
Methods of Treating Multiple Sclerosis
Application:
62/140,255 →
Lingo-1 Antagonists and Uses for Treatment of Demyelinating Disorders
Application:
62/147,783 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.